CED Digest: 50 Items — April 02, 2026

Alabama Medical Cannabis Sales Gear for Spring 2026 Launch

Alabama’s medical cannabis program is preparing to begin dispensary sales in spring 2026, establishing legal patient access to cannabis products under clinical oversight.

Cannabis compounds CBD and CBG may help reverse fatty liver disease, study finds

Cannabis compounds CBD and CBG show potential therapeutic effects against fatty liver disease in research, offering clinicians evidence-based cannabinoid options for metabolic disorder management.

From Billion-Dollar Hemp Drinks to FDA Cease-and-Desist Letters: The Cannabis Industry’s …

The cannabis industry faces regulatory challenges as FDA enforcement actions target hemp-derived products marketed with health claims, affecting clinical product recommendations and patient access to cannabinoid therapies.

Cannabis Compounds CBD and CBG Show Promise in Reducing Liver Fat and Improving …

**CBD and CBG demonstrate potential therapeutic effects on hepatic steatosis, representing clinically relevant findings for managing metabolic liver disease in cannabis medicine practice.**

New Cannabis Group Will Help Ground Policy In Science And Patient Experience As …

New Top Cannabis Regulator Sets Priorities In First Board Meeting

A newly appointed cannabis regulator outlined their initial priorities at their first board meeting, establishing direction for industry oversight and compliance standards affecting clinical practice.

Brazil’s Cannabis Crossroads: New Rules, Old Truths, and the Road Ahead

Brazil’s evolving cannabis regulations create new clinical opportunities while presenting implementation challenges for healthcare providers navigating legal, medical, and patient access frameworks.

2 Greater Cincinnati breweries file lawsuit over Ohio ban on THC beverages – WLWT

Two Greater Cincinnati breweries are challenging Ohio’s ban on THC-infused beverages through legal action, directly impacting regulated cannabis product availability and clinician recommendations in the state.

New Ohio law means THC-infused drinks won’t be available on many store shelves – WTVG

Ohio’s new law restricts THC-infused beverage distribution in retail settings, affecting clinicians’ ability to recommend and patients’ access to cannabis beverage products as treatment options.

Lawmakers strike down bill capping THC levels in Oregon’s cannabis edibles – Yahoo

Attempt to limit potency of THC in marijuana edibles fails at Oregon Legislature

Oregon legislators failed to pass a bill limiting THC potency in marijuana edibles, leaving clinicians without regulatory guidance on product strength and dosing safety for patients.

Cannabis Compounds CBD and CBG Slash Liver Fat and Restore Metabolic Health

CBD and CBG reduced hepatic steatosis and improved metabolic markers in research, relevant for clinicians evaluating cannabis use in patients with fatty liver disease or metabolic dysfunction.

Cannabinoid Oral Mucosal Delivery: Approaches to Formulation, Fabrication, and … – PubMed

This article examines formulation and fabrication methods for oral mucosal cannabis delivery systems, relevant to clinicians seeking alternative administration routes beyond smoking or standard ingestion.

Study: CBD-Dominant Cannabis Products Provide Significant Anxiety Relief – NORML

CBD-dominant cannabis products demonstrate clinical efficacy for anxiety treatment, providing evidence-based therapeutic options for clinicians evaluating cannabinoid interventions in patient care.

Clinical Trial: Cannabis Extracts Significantly Reduce Myofascial Pain – NORML

A clinical trial demonstrates cannabis extracts’ efficacy in reducing myofascial pain, providing evidence-based data clinicians can reference when evaluating treatment options for patients with this condition.

As a Medical Cannabis Patient, I’m Watching This Supreme Court Case Closely

A medical cannabis patient discusses a Supreme Court case’s potential implications for patient access and medical cannabis legal status, relevant to clinical practice and patient care.

The Week in Weed: March 2026 | Seyfarth Shaw LLP – JDSupra

**Please share the article content, and I’ll provide the requested summary.**

Marijuana gummies sold in Ohio recalled. Why, where they were sold – The Columbus Dispatch

Marijuana gummies distributed in Ohio were recalled, requiring clinicians to verify product safety and counsel patients on potential risks from affected batches.

New Group Launches Ahead of Medicare CBD Pilots – Cannabis Wire

A new organization formed to prepare for Medicare’s upcoming cannabidiol pilot programs, relevant for clinicians seeking to understand regulatory pathways for CBD in federally insured patient populations.

Marijuana Status Based Prohibition Tag Archives – Powers Law Firm PA

This archive covers legal prohibition status of marijuana across jurisdictions, relevant for clinicians navigating varying regulatory frameworks affecting patient care and medical practice.

Louisiana lawmaker files bill to legalize recreational marijuana through licensed dispensaries

Louisiana legislator proposes legalizing recreational cannabis sales through regulated dispensaries, directly impacting clinical practice by expanding legal access and requiring clinicians to understand new regulatory frameworks.

Mom’s homemade medical cannabis recipe now being sold at Georgia dispensaries

A Georgia mother’s homemade medical cannabis formulation has been commercialized for dispensary sale, representing patient-developed preparations entering regulated retail markets.

Ohio THC drink ban draws lawsuit from Cincinnati breweries

Ohio’s THC beverage restriction is legally challenged by breweries, creating regulatory uncertainty that affects cannabis clinicians’ counseling on product availability and legal consumption options for patients.

Israeli researchers find cannabis compounds could lead to 1st drug for fatty liver disease

Israeli researchers identified cannabis compounds as potential treatments for fatty liver disease, representing the first drug development pathway for this condition affecting millions globally.

Virginia adult-use sales bills pass both chambers, head to conference committee! – Blog

Virginia’s legislature advanced adult-use cannabis sales bills through both chambers, requiring conference committee reconciliation before determining legal sales framework implementation for clinicians’ patient populations.

Study highlights pros, cons of medical marijuana as its future in Tennessee remains unknown

This article examines both benefits and risks of medical cannabis, relevant to clinicians in Tennessee where its legal status and clinical applications remain uncertain.

2026 Utah legislature on cannabis, psychedelics and kratom – Fox 13

The 2026 Utah legislature’s positions on cannabis, psychedelics, and kratom regulation directly impact clinical practice options and patient access to these substances in Utah.

Oregon Bill To Ban Marijuana Edibles With More Than 10 Milligrams Of THC Fails

Oregon’s proposed legislation to cap THC content in cannabis edibles at 10 milligrams per unit failed, maintaining current higher dosing limits and affecting clinical dosing protocols and patient safety considerations.

Georgia bill could limit probable cause for smell of marijuana, cannabis, or hemp – YouTube

Georgia legislation would restrict police from using marijuana smell alone as probable cause for searches, affecting how legal cannabis patients interact with law enforcement.

Study reveals cannabis compounds reduce threat of fatty liver disease | Health

Cannabis compounds show potential to reduce fatty liver disease risk, providing clinicians with evidence-based information for patient counseling regarding hepatic health outcomes.

Prescription Cannabidiol CBD Oil Market to Hit US$ 190.9 Billion by 2032 at 23.48% CAGR

The prescription CBD oil market is projected to reach $190.9 billion by 2032 with 23.48% annual growth, indicating significant expansion in clinical cannabinoid therapeutics and market opportunities.

TPS Cannabis News – StratCann

InMed Pharmaceuticals Shifts Focus to Therapeutic Programs, Ends BayMedica’s Non …

Cannabis Extracts Significantly Reduce Myofascial Pain | Trending – Labroots

(30 words)

Pediatricians warn about cannabis use disorder, kids’ easy access to the drug – YouTube

Pediatricians highlight cannabis use disorder risks in children and concerning accessibility barriers, relevant to clinicians managing adolescent cannabis patients and prevention strategies.

West Virginia House Passes Bill To Allocate Medical Marijuana Revenue, With Some …

West Virginia legislators approved funding allocation for medical marijuana revenue, establishing financial mechanisms for the state’s cannabis program implementation.

Study highlights positive, negatives of medical marijuana – WKRN News 2

A news article examining research findings on medical marijuana’s therapeutic benefits and adverse effects, relevant for clinicians evaluating treatment efficacy and safety profiles.

The science behind roadside THC testing and diving into SGI’s zero-tolerance policy – Global News

This article examines roadside THC testing methods and Saskatchewan Government Insurance’s zero-tolerance impaired driving policy, relevant to clinicians managing patient safety and legal implications of cannabis use.

Mom’s homemade medical cannabis recipe now being sold at Georgia dispensaries

A Georgia mother’s homemade medical cannabis formulation has entered commercial dispensary distribution, demonstrating patient-developed preparation methods now reaching clinical retail channels.

‘Pot for Potholes Act’ aims to legalize marijuana in Tennessee and distribute taxes to repair …

Tennessee legislation proposes legalizing marijuana while dedicating tax revenue to infrastructure repair, directly affecting clinicians’ ability to legally recommend cannabis and access clinical data in their state.

One of Colorado’s Largest Dispensary Chains Agrees to Buyout – Denver Westword

A major Colorado dispensary chain is undergoing acquisition, potentially affecting patient access, product availability, and pricing structures in the state’s cannabis market.

Cannabis legalization driving increases in marijuana use among US adults with historically … – MSN

**Cannabis legalization is associated with rising marijuana use among US adults in historically marginalized populations, which clinicians must monitor for health outcomes and health equity implications.**

Ohio Department of Commerce recalls certain marijuana gummies lacking THC symbol … – Facebook

Ohio’s Department of Commerce recalled marijuana gummies missing required THC labeling symbols, affecting product safety compliance and patient identification of psychoactive content.

Perceptions of the relative harmfulness of marijuana and alcohol among adults in Oregon.

This study examines how Oregon adults perceive marijuana and alcohol’s relative health risks, providing clinicians with data on patient risk perception that influences clinical counseling and treatment decisions.

What’s Really Happening With Cannabis ETF MSOS? – The Dales Report

This article examines the performance and factors affecting the MSOS cannabis ETF, relevant to clinicians tracking industry financial health and market access for cannabis medicine.

Study reveals cannabis compounds reduce threat of fatty liver disease – Daily Journal

Cannabis compounds may reduce fatty liver disease risk, which is clinically relevant for cannabinoid-based treatment considerations in patients with liver pathology.

Scientists are raising new concerns about marijuana use in teens – KPBS

This article examines research linking adolescent cannabis use to psychiatric risks including psychosis, depression, and anxiety, relevant for clinicians assessing teen patients’ neuropsychiatric vulnerability during brain development.

Clinical Trial: Cannabis Extracts Significantly Reduce Myofascial Pain – NORML

Sublingual cannabis extracts reduced myofascial pain in temporomandibular disorder patients, expanding treatment options for a condition resistant to conventional pharmacotherapy.

Can the placenta predict schizophrenia risk? Lessons from prenatal cannabis exposure

This research examines placental biomarkers as potential early predictors of schizophrenia risk following prenatal THC exposure, relevant for clinicians counseling pregnant patients about cannabis use effects on fetal neurodevelopment.

Scientists are raising new concerns about marijuana use in teens – YouTube

This article covers adolescent cannabis use risks, emphasizing THC’s impact on brain development through the mid-twenties and associations with disruption—critical knowledge for clinicians treating young patients.

The digest reflects a bifurcation in cannabis research and policy: on one hand, there is accumulating preclinical and clinical evidence for cannabinoid efficacy in specific conditions such as fatty liver disease, anxiety, and myofascial pain, which warrants continued rigorous study; on the other hand, regulatory frameworks remain fragmented and inconsistent across jurisdictions, with ongoing disputes over potency limits and product categories that complicate both clinical application and public health messaging. The emergence of stricter regulatory oversight, exemplified by new regulator appointments and FDA enforcement actions, suggests a gradual shift toward more evidence-based governance, though significant gaps remain between the pace of policy change and the supporting clinical data.

FAQ

This News item was assembled from structured source metadata and pipeline scoring.